Clinical Trial Update: A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy [Phase 2]

View source ↗

Summary

This is a Phase II study evaluating T-cell clonality after stereotactic body radiotherapy alone and in combination with the immunocytokine PDS01ADC in localized…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PDS01ADC

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer Of Prostate | Phase 2 | Status: RECRUITING